Search Results - "Røe, Oluf D."

Asbestos textile production linked to malignant peritoneal and pleural mesothelioma in women: Analysis of 28 cases in Southeast China by Gao, Zhibin, Hiroshima, Kenzo, Wu, Xiaodong, Zhang, Jixian, Shao, Dichu, Shao, Huajiang, Yang, Hanqing, Yusa, Toshikazu, Kiyokawa, Takako, Kobayashi, Makio, Shinohara, Yasushi, Røe, Oluf D., Zhang, Xing, Morinaga, Kenji

“…Background Chrysotile had been used in asbestos textile workshops in Southeast China but a clear relation to mesothelioma is lacking. Methods All patients…”
Get full text

Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry by Sandeck, Helmut P, Røe, Oluf D, Kjærheim, Kristina, Willén, Helena, Larsson, Erik

“…In order to provide reliable tissue material for malignant mesothelioma (MM) studies, we re-evaluated biopsies and autopsy material from 61 patients with a…”
Get full text

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma by Panou, Vasiliki, Gadiraju, Meghana, Wolin, Arthur, Weipert, Caroline M, Skarda, Emily, Husain, Aliya N, Patel, Jyoti D, Rose, Buerkley, Zhang, Shannon R, Weatherly, Madison, Nelakuditi, Viswateja, Knight Johnson, Amy, Helgeson, Maria, Fischer, David, Desai, Arpita, Sulai, Nanna, Ritterhouse, Lauren, Røe, Oluf D, Turaga, Kiran K, Huo, Dezheng, Segal, Jeremy, Kadri, Sabah, Li, Zejuan, Kindler, Hedy L, Churpek, Jane E

“…The aim of the current study was to determine the prevalence and clinical predictors of germline cancer susceptibility mutations in patients with malignant…”
Get full text

Recombinant human endostatin (endostar) decreased recurrent ascites, pleural fluid and ascitic VEGF in a case of advanced mesothelioma by Chen, Xiaofeng, Liu, Yiqian, Yin, Yongmei, Jin, Shidai, Ping, Guoqian, Røe, Oluf D, Yan, Keli, Shu, Yongqian, Guo, Renhua

“…We report a case of 43-year-old male with advanced malignant mesothelioma (MM) with a large amount of fluid in the pleural and peritoneal cavity. The addition…”
Get full text

Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium by Bjerner, Johan, Bratt, Ola, Aas, Kirsti, Albertsen, Peter C., Fosså, Sophie D., Kvåle, Rune, Lilja, Hans, Müller, Christoph, Müller, Stig, Stensvold, Andreas, Thomas, Owen, Røe, Oluf D., Vickers, Andrew, Walz, Jochen, Carlsson, Sigrid V., Oldenburg, Jan

“…Among 40- to 70-yr-old men with a “normal” prostate-specific antigen (PSA) value (below 4 ng/ml) sampled in routine medical care, the risk of dying from…”
Get full text

Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway by Robles, Ana I, Olsen, Karina Standahl, Tsui, Dana W T, Georgoulias, Vassilis, Creaney, Jenette, Dobra, Katalin, Vyberg, Mogens, Minato, Nagahiro, Anders, Robert A, Børresen-Dale, Anne-Lise, Zhou, Jianwei, Sætrom, Pål, Nielsen, Boye Schnack, Kirschner, Michaela B, Krokan, Hans E, Papadimitrakopoulou, Vassiliki, Tsamardinos, Ioannis, Røe, Oluf D

“…The goal of biomarker research is to identify clinically valid markers. Despite decades of research there has been disappointingly few molecules or techniques…”
Get full text

Prediction of 6-year risk of bladder cancer using the HUNT Lung Cancer Risk Model in ever-smokers: A HUNT study by Røe, Oluf D., Nguyen, Olav Toai Duc, Fotopoulos, Yannis, Lagani, Vincenzo, Tsamardinos, Ioannis

“…e16581 Background: Bladder cancer is the 6th most common cancer in men and 17th most common cancer in women and the mortality is high when detected in advanced…”
Get full text

Improvement of lung cancer risk prediction adding SNPs to the HUNT Lung Cancer Model: A HUNT Study by Røe, Oluf D., Nguyen, Olav Toai Duc, Lakiotaki, Klio, Tsamardinos, Ioannis, Lagani, Vincenzo, Markaki, Maria

“…Abstract only e20696 Background: A novel validated model for risk prediction of lung cancer, the HUNT Lung Cancer Model predicts 6- and 16-year risk of lung…”
Get full text

Abstract 481: Utility of hCG as a biomarker of treatment response in advanced urothelial cancer: A population based series at Akershus University Hospital, Norway by Puco, Katarina, Bjerner, Johan, Müller, Stig, Lilleaasen, Gunder M., Husby, Haldor, Røed-Undlien, Mattias, Heinrich, Daniel, Dahl, Fredrik A., Røe, Oluf D., Oldenburg, Jan

“…Background Treatment options in patients with advanced urothelial carcinoma (aUC) have improved significantly in the last decade, highlighting the need for…”
Get full text

Long-term predictive value of serum PSA values obtained in clinical practice: Results from the Norwegian Prostate Cancer Consortium (NPCC) by Oldenburg, Jan, Bjerner, Johan Lars, Lilja, Hans, Aas, Kirsti, Fossa, Sophie D., Mueller, Christoph, Mueller, Stig, Thomas, Owen, Stensvold, Andreas, Walz, Jochen, Røe, Oluf D., Bratt, Ola, Carlsson, Sigrid V.

“…5021 Background: A baseline prostate-specific antigen (PSA) level in midlife is strongly associated with risk of lethal prostate cancer several decades later…”
Get full text

Proteomics analysis discovers biomarkers in serum months to years before small cell lung cancer: The HUNT study by Nguyen, Olav Toai Duc, Markaki, Maria, Chatzipantsiou, Christina, Sharma, Animesh, Lagani, Vincenzo, Tsamardinos, Ioannis, Røe, Oluf D.

“…Abstract only e20095 Background: The high incidence and high mortality rate of small-cell lung cancer (SCLC) calls for identification of methods for early…”
Get full text

DNA repair suppression and effect of cisplatin in mesothelioma and lung cancer cell lines by Røe, Oluf D., Chen, Wu, Zhi, Xiaofei, Chen, Duan, Chen, Yijiang

“…Abstract only e13542 Background: Recently we characterized a gene profile with overexpressed DNA double strand repair systems in mesothelioma versus normal…”
Get full text

Postoperative leukopenia as an independent prognostic factor in gastric cancer patients by Chen, Xiaofeng, Pei, Dong, Røe, Oluf D., Qian, Jing, Zhu, Fang, He, Shaohua, Qian, Yingying, Liu, Yiqian, Yin, Yongmei, Yongqian, Shu

“…Abstract only…”
Get full text

Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation by Szejniuk, Weronika Maria, McCulloch, Tine, Røe, Oluf Dimitri

“…We describe three cases of patients with advanced adenocarcinoma of the lung and epidermal growth factor receptor (EGFR) mutation treated with erlotinib 25…”
Get full text

Pemetrexed as first or second line in 112 danish patients by Panou, Vasiliki, Nielsen, Ida, Soerensen, Jens Benn, Roe, Oluf D.

“…Abstract only…”
Get full text

Serum microRNAs/enriched pathways in lung cancer 1-4 years before diagnosis: A pilot study from the HUNT Biobank, Norway by Roe, Oluf D., Markaki, Maria, Mjelle, Robin, Sætrom, Pål, Tsamardinos, Ioannis, Lagani, Vincenzo

“…Abstract only…”
Get full text

Exon 20-Mutated NSCLC: Extending the Data Set to Allow the Recognition of Potential Causes by van Zandwijk, Nico, Amos, Christopher I., Røe, Oluf Dimitri, Reid, Glen, Klebe, Sonja

Get full text

Preoperative Serum Soluble Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin Predict Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Valve Surgery by Cao, Hailong, MD, PhD, Zhou, Qing, MD, Wu, Yanhu, MD, Li, Qingguo, MD, PhD, Røe, Oluf Dimitri, MD, PhD, Chen, Yijiang, MD, PhD, Wu, Zhong, MD, PhD, Wang, Dongjin, MD, PhD

“…Background Postoperative atrial fibrillation (POAF), a frequent complication after cardiac surgery, causes morbidity and prolongs hospitalization. A…”
Get full text